CTEV

NYSE Healthcare

Claritev Corporation Class A Common Stock

Health Information Services

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.

๐Ÿ“Š Market Data
Price$28.34
Volume118,873
Market Cap483.13M
Beta0.770
RSI (14-Day)49.7
200-Day MA$37.96
50-Day MA$21.11
52-Week High$74.07
52-Week Low$11.50
Forward P/E4.14
Price / Book-2.00
๐ŸŽฏ Investment Strategy Scores

CTEV scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
๐Ÿš€ Moon Shot 44/100โ–ผ -5
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 89/100โ–ผ -4
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 41/100โ–ฒ +6
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿ”ช Falling Knife (89/100) โ€” this strategy Contrarian plays (oversold + below moving average).

Lowest fit among scored strategies: ๐Ÿ‹ Institutional Whale (13/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find CTEV in your text

Paste any article, transcript, or post โ€” the tool will extract CTEV and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-06-02.